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Inborn cardiac diseases are among the most frequent congenital anomalies and are the
main cause of death in infants within the ﬁrst year of age in industrialized countries when
not adequately treated.They can be divided into simple and complex cardiacmalformations.
The former ones, for instance atrial and ventricular septal defects, valvular or subvalvular
stenosis or insufﬁciency account for up to 80% of cardiac abnormalities.The latter ones, for
example transposition of the great vessels,Tetralogy of Fallot or Shone’s anomaly often do
not involve only the heart, but also the great vessels and although occurring less frequently,
these severe cardiac malformations will become symptomatic within the ﬁrst months of
age and have a high risk of mortality if the patients remain untreated. In the last decade,
there is increasing evidence that cardiac gap junction proteins, the connexins (Cx), might
have an impact on cardiac anomalies. In the heart, mainly three of them (Cx40, Cx43,
and Cx45) are differentially expressed with regard to temporal organogenesis and to their
spatial distribution in the heart. These proteins, forming gap junction channels, are most
important for a normal electrical conduction and coordinated synchronous heart muscle
contraction and also for the normal embryonic development of the heart. Animal and also
some human studies revealed that at least in some cardiac malformations alterations in
certain gap junction proteins are present but until today no particular gap junction mutation
could be assigned to a speciﬁc cardiac anomaly. As gap junctions have often been supposed
to transmit growth and differentiation signals from cell to cell it is reasonable to assume that
they are somehow involved in misdirected growth present in many inborn heart diseases
playing a primary or contributory role. This review addresses the potentional role of gap
junctions in the development of inborn heart anomalies like the conotruncal heart defects.
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INTRODUCTION
Congenital heart defects belong to the most frequent inborn
anomalies with a prevalence of about 10 out of 1000 live births
(Schwedler et al., 2011). The pathology ranges from moderate
defects like atrial septal defects (ASDs) or ventricular septal defects
(VSDs), patent ductus arteriosus or pulmonary valve stenosis up
to severe and complex heart diseases like Morbus Fallot, hypoplas-
tic right or left heart syndrome, transposition of the great arteries
(TGA), Ebstein’s malformation or Truncus arteriosus communis
(TAC). Depending on the severity of the heart disease clinical
course varies from spontaneous recovery up to the necessity for
multiple surgical interventions and a life-long medical treatment.
Nowadays, as pediatric surgery achieved a high level of standard
most of the children have a good prognosis with respect to life
expectancy and most of them may reach adulthood.
Interestingly, inborn cardiac diseases tend to occur with
increased frequency in familial clusterswith a signiﬁcantly elevated
risk for cardiac malformations in ﬁrst degree relatives, siblings or
twins. Regarding the latter ones: the prevalence of an inborn heart
disease, if either of the twins is affected, is considerably higher
for a monozygotic twin sibling compared to a dizygotic twin sib-
ling (Mitchell et al., 1971; Wang et al., 2012). Additionally, if in
a monozygotic twinship both twins exhibit any congenital heart
defect, then with over 90% incidence both will have the same heart
malformation (Seides et al., 1979).
However, up to present the precise cause for the develop-
ment of an inborn heart disease remains unknown. There are
several reports about the inﬂuence of exogenous noxa, chromo-
somal aberration, and genetic and environmental factors, but
even for inborn cardiac defects which occur together with well-
deﬁned gene variants, for instance the Holt–Oram syndrome
or Noonan syndrome (the so-called Mendelian syndromes) or
are associated with chromosomal anomalies (for instance Tri-
somie 18 or 21), the penetrance of the cardiac defect does not
reach 100%, and also the type of cardiac defect (i.e., ASD or
VSD, pulmonary valve stenosis, etc.) is not identical within a
speciﬁc syndrome (van der Bom et al., 2011). Thus, it seems
obvious that inborn cardiac diseases have a multifactorial gene-
sis and the etiology of most cases remains uncertain (Nora, 1968;
Blue et al., 2012).
In the last decade, increasing evidence appeared that cardiac
gap junction proteins, the connexins (Cx), might have an impact
on cardiac anomalies. In the heart, mainly three of them (Cx40,
Cx43 and Cx45) are differentially expressed with regard to tem-
poral organogenesis and spatial distribution. The connexins are
named after their molecular weight and the species in which they
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occur, i.e., the human Cx43 (hCx43) has a molecular weight of
approximately 43 kDa (Eiberger et al., 2001).
Connexin proteins form gap junction channels, which can be
considered as pore-like channels permeable for cations, anions,
and small molecules with low molecular weights (Simpson et al.,
1977). A complete dodecameric gap junction channel is composed
of two hemichannels (connexons) contributed by two adjacent
cells and one hemichannel consists of six protein subunits. The
connexins are transmembrane proteins with four transmembrane
domains (M1–M4), two extracellular loops (E1, E2), one intracel-
lular loop, and the N- and C-terminus at the cytoplasmic side of
the cell (Unwin and Zampighi, 1980). The C-terminus, which is
the most variant part of a connexin differs in length and amino
acid sequence and also contains various consensus sequences for
a number of protein kinases. For the Cx43 protein it is known
that protein kinase A and C (PKA and PKC), mitogen-activated
protein kinase, cyclin kinase 1, and some more precisely regulate
Cx43 turnover as well as gap junctional communication (Lampe,
1994; Kwak et al., 1995; TenBroek et al., 2001; Polontchouk et al.,
2002; Lampe and Lau, 2004). Its protein structure with its phos-
phorylation sites is presented in Figure 1 (according to Giepmans,
2004). Besides Cx43 phosphorylation sites have also been identi-
ﬁed within the C-terminal tail of Cx40 and Cx45 which alter their
channel permeability and electrophysiological properties (Lampe
and Lau, 2004).
It is known that some cardiac connexins, particularly Cx43,
have considerable short half-lives of about 2–3 h (Darrow et al.,
1995; Beardslee et al., 1998). Such a short half-life suggests that
the permanent adaptation of the communication structure (i.e.,
the gap junctions) to environmental conditions might be of pro-
nounced importance for cardiac cells and alsomight point towards
a large functional relevance of connexins in ensuring cardiac devel-
opment and function. As an example, it was shown that Cx43
changed its localization quickly after starting cyclic mechanical
stretch (within 24 h) from a circumferential distribution to an
accentuation at the cell poles; similarly polar accentuation was
lost after discontinuation of stretch (Salameh et al., 2010). This
shows how cells adapt their communication structure (given by
the geometric distribution of Cx43) to an external factor (cyclic
mechanical stretch) with a time span of 8–12 times the half-life
time of Cx43, which is a reasonable period to assume a complete
turnover of the protein.
In the human adult heart, the spatial distribution of the three
connexins (Cx40, Cx43, and Cx45) is not uniform, as they are
localized in specialized compartments: atrial myocytes express
both Cx40 and Cx43 at similar levels whereas Cx45 is much lower
in the atria. In the ventricles, the dominant connexin is Cx43 and
in the sinus node and the conduction system of the heart both
Cx40 and Cx45 are found (Davis et al., 1995). This non-uniform
distribution is the basis for a regular impulse formation, a normal
electrical conduction and coordinated synchronous heart muscle
contraction. Furthermore, in order to allow regular rhythmic acti-
vation of the heart the connexins are typically assembled to gap
junction channels at the intercalated disks which are located at
the cell poles (Peters et al., 1994; van Rijen et al., 2006). This facil-
itates conduction of the action potential from cell to cell along
the cell axis (Dhein et al., 2011). However, connexins also exist at
FIGURE 1 | Connexin topology with phosphorylation sites and ZO-1
binding region. Cdc2, cyclin dependent kinase 2; CK1, casein kinase 1;
MAPK, mitogen-activated protein kinase; PKA, protein kinase A; PKC,
protein kinase C; PKG, protein kinase G; ZO-1, zonula occludens protein 1.
the lateral border of the cells but at lower abundance. This results
in a fast conduction along the ﬁber axis and a slower conduction
transverse to the axis (Dhein et al., 2011).
Besides their functions in the adult heart, the connexins are also
most important for the normal embryonic heart development.
Studies in mice revealed that Cx40 is initially expressed in
the atrial compartments and later in both ventricles, whereas its
expression is turned up earlier in the left ventricle. In contrast to
Cx43, Cx40 it is not expressed within the muscular structures of
the interventricular septum. However, Cx40 is expressed in the
His-Bundle and the bundle branches. Cx43 is seen in both ven-
tricles and the interventricular septum in early development and
later on also in the atrial compartments. In the conduction sys-
tem Cx43 is not represented (Delorme et al., 1997; Alcoléa et al.,
1999). Cx45 is in early cardiogenesis the only connexin expressed
in all cardiac compartments and its loss resulted in conduction
block and cushion defects with lethal outcome at embryonic day
10 (Kumai et al., 2000; Nishii et al., 2001). During further mor-
phogenesis it is progressively down-regulated and absent in the
adult mouse ventricle. The expression pattern of connexins dur-
ing development of the human heart is less well examined, but the
connexin labeling pattern in human fetal heart resembles that of
the mouse heart, with the exception that in the atria of human
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fetal hearts Cx43 is only expressed at very low levels whilst in the
mouse heart it is abundant (Kaba et al., 2001; Coppen et al., 2003).
Thus, although comprehensive analyses are still missing, at least
to some extent connexin expression pattern in the mouse heart
parallels that of human fetal hearts.
Furthermore, to stress the importance that not only the cor-
rect temporal expression of a connexin is essential for normal
heart growth but also the level of connexin expression, stud-
ies in mice revealed that both homozygous Cx43 knock-out and
Cx43 over-expression may result in outﬂow tract obstruction and
conotruncal cardiac malformations (Reaume et al., 1995; Ewart
et al., 1997). This, demonstrates the importance of an exact regu-
lation of Cx43-expression for normal heart growth. What is most
interesting is that in a mouse model a point mutation in the Cx43
gene led to a reduction in Cx43 expression, a reduction in gap
junction coupling and a disruption of gap junction plaque assem-
bly. These changes were accompanied by cardiac defects like patent
foramen ovale, enhanced ﬁbrosis, worsening of right and left ven-
tricular function, and also conduction anomalies. Extracardial
changes resembled the syndrome of oculodentodigital dysplasia
(ODDD; Flenniken et al., 2005). This inborn syndrome is also seen
in man and up to today over 60 mutations in the Cx43 gene have
been described associatedwith this syndrome. Unlike the situation
in mice, human cardiac malformations are not very common in
ODDD. In man, only in few cases of ODDD conduction anoma-
lies (atrioventricular block, right bundle branch block) and the
appearance of VSDs and pulmonary stenosis have been described
(Paznekas et al., 2003, 2009).
Moreover, a study with Cx40 knock-out mice demonstrated
the importance of this connexin in generation of the mature apex
to base activation of the heart (Sankova et al., 2012). Additionally,
Kirchhoff et al. (2000) reported on variousmice knock-outmodels
with either Cx40 and/or Cx43 homozygous or heterozygous abla-
tion with the occurrence of conduction anomalies and cardiac
malformations (ASDs or VSDs, myocardial hypertrophy). In their
study, the authors also found out that Cx43 haploinsufﬁciency
even impaired the morphological phenotype of Cx40 deﬁciency.
This was conﬁrmed by another study of Simon et al. (2004) who
detected malformed ventricles with an abnormal orientation in
Cx40 and Cx43 double knock-out mice.
Conotruncal malformations, including TAC (birth preva-
lence 0.011%), double outlet right/left ventricle (birth prevalence
0.016%), Tetralogy of Fallot (TOF; birth prevalence 0.042%), and
TGA (birth prevalence 0.032%; van der Bom et al., 2012), typically
show malformations of the cardiac outﬂow tract. The critical time
frame for the origination of conotruncal heart defects seems to be
the ﬁfth week of human embryonic development. At this speciﬁc
moment in time the common outﬂow tract of the right and left
heart, the Truncus arteriosus, is divided by a spiral shaped septum
which ensures the correct association of the great arteries to the
corresponding ventricles. Depending on the nature of malforma-
tion of the aorticopulmonary septum the afore mentioned cardiac
defects may occur: a complete absence of the septum results in
the development of TAC (common arterial trunk), lack of septal
spiralization leads to TGA and anterior malalignment of the sep-
tum together with incomplete closure to double outlet right/left
ventricle or TOF.
Hence, it is conceivable that the genesis of these cardiac
defects might have the same etiopathologic origin and since
the connexins play an important role in cardiac development it
might be possible that certain alterations in temporal or spatial
distribution of the main cardiac connexins may be at least co-
responsible for conotruncal malformations. On the other side, it
may also be imagined that conotruncal malformations themselves
may secondarily lead to alterations in connexin expression and
distribution.
Nearly 20 years ago, Britz-Cunningham et al. (1995) ana-
lyzed Cx43 mutations in patients with cardiac malformations and
defects of laterality and they found missense mutations in parts
of the Cx43 gene encoding for consensus phosphorylation sites
within the Cx43 C-terminus. The authors could demonstrate that
these mutations altered Cx43 phosphorylation by PKA or PKC,
bothprotein kinases known tobe important forCx43–intercellular
communication.
With these very interesting and new observations the authors
started aworld-wide discussion onwhether or notCx43mutations
are responsible or at least partly responsible for the development
of cardiac malformations.
Therefore, the aim of this review is to discuss today’s knowledge
of connexin alterations in human conotruncal heart defects and
the possible impact of connexins on the development of the same.
TRUNCUS ARTERIOSUS COMMUNIS
Truncus arteriosus communis can be classiﬁed into three different
types depending on the outﬂow of the pulmonary artery: type 1
(rare): pulmonary trunk originates from the lateral wall of theTAC
and branches into one left and one right pulmonary artery; type
2 (common type): two pulmonary arteries with proximate origins
separately branch off from the posterolateral aspect the common
arterial trunk; type 3 (rare): both pulmonary arteries originate
separately from the left and right lateral side of the common trunk.
The symptoms of this heart defect include right heart hypertrophy,
pulmonary overﬂow with consecutive pulmonary hypertension,
Eisenmenger’s syndrome, and heart failure (Figure 2 gives the
normal cardiac anatomy, in Figure 3, TAC type 3 is depicted).
The clinical picture of TAC is often associated with the
DiGeorge syndrome (2q11 microdeletion, conotruncal heart mal-
formations, thymic and parathyroid hypoplasia, cleft palate, and
facial dysmorphism). This inborn malady is evoked by distur-
bances in the migration of the cardiac neural crest cells. Kirby
et al. (1983) have demonstrated in their seminal study done in
chick embryos that ablation of a certain portion of the neural
crest cells resulted in conotruncal heart defects including common
arterial trunk. More recently, Huang et al. (1998a,b) could show in
mice embryos that alterations in Cx43 gene dosage also resulted
in conotruncal heart defects with pathologic morphology of the
right ventricle, thinning of the myocardium and narrowing of
the right ventricular outﬂow tract (RVOT). Moreover, they could
demonstrate that gap junctional communication was increased in
neural crest cells of Cx43 overexpressing mice and decreased in
those of Cx43 knock-out mice. This phenomenon was accompa-
nied by corresponding migration changes in the cardiac neural
crest cells and by a perturbation of cardiomyocyte proliferation.
Thus, the authors concluded that intercellular communication in
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FIGURE 2 | Normal cardiac anatomy.The blue arrows give the ﬂow of oxygen-poor blood from both caval veins via the right atrium and the right ventricle to the
left and right pulmonary artery. The red arrows give the ﬂow of oxygen-rich blood from the pulmonary veins via the left atrium and the left ventricle to the aorta.
FIGURE 3 |Truncus arteriosus communis. Both great arteries (i.e.,
pulmonary artery and aorta) emerge together from a solitary arterial
trunk. The blue arrows give the ﬂow of oxygen-poor blood from both
caval veins via the right atrium and the right ventricle and via the
truncus valve to theTruncus arteriosus communis. The red arrows
give the ﬂow of oxygen-rich blood from the pulmonary veins via
the left atrium and the left ventricle to theTruncus arteriosus
communis.
cardiac neural crest cells might be important for the myocardial-
ization of the ventricular outﬂow tract, i.e., the regular shaping of
the outﬂow septum. The impact of Cx43 on the development of
the aorticopulmonary septum was underlined by a study of Waller
et al. (2000) who also found that gain or loss of Cx43 function
results in outﬂow tract anomalies and preferentially in persis-
tent arterial trunk. In addition, induction of mutagenesis with
N-ethyl-N-nitrosourea in mice revealed that in the Cx43 gene
a G to A substitution which generated a premature stop codon
was sufﬁcient to cause conotruncal malformation and coronary
aneurysms (Yu et al., 2004). In addition to this result, Yu et al.
(2004) also reported on a point mutation within another pro-
tein, the semaphorin, which resulted in common arterial trunk
and interrupted aortic arch. Since the semaphorin family is sup-
posed to give environmental cues for the migration of neural crest
cells (Brown et al., 2001) it seems clear that perturbation of neural
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crest cell migration might hinder the correct formation of the
arterial trunk. This viewpoint is also supported by the excellent
review of Hutson and Kirby (2003), who pointed out that aortic
arch formation and outﬂow tract septation deeply depend on a
correct deployment of cardiac neural crest cells. However, Cx43
is obviously not the only responsible factor for cardiac neural
crest migration: there are several other protein families including
growth factors [i.e., ﬁbroblast growth factor, bone morphogenetic
protein (BMP) or Wnt signaling pathway] as well as transcription
factors (i.e., AP2, Sox9, FoxD) or adhesion molecules like N-
cadherin being responsible for cardiac neural crest development.
These factors and pathways are outlined in the comprehensive
review of Kirby and Hutson (2010). Therefore, it can be con-
cluded from the aforesaid that disturbances in Cx43-expression
are very important factors in the pathogenesis of TAC but not the
sole ones.
There are no experimental studies existing on the potential
inﬂuence of Cx40 or Cx45 on the development of persistent
arterial trunk.
TRANSPOSITION OF THE GREAT ARTERIES
The hallmark of this cardiac malformation is the ventriculoar-
terial discordance in such a way that the aorta arises from the
morphological right ventricle and the pulmonary artery from the
morphological left ventricle with bothmain vessels remaining par-
allel to each other (i.e., they do not cross over, which would be the
normal condition; Martins and Castela, 2008; Figure 4). More-
over, atypical origins of the coronary arteries and VSDs or ASDs
are not uncommon. Depending on whether the aorta is located on
the right or left side of the pulmonary artery this cardiac malfor-
mation is sub-classiﬁed into d(exter)- or l(aevus)-transposition,
respectively. Additionally, a distinction can be made between
complete transpositions, i.e., concordant atrioventricular and dis-
cordant ventriculoarterial connections (the atria are connected to
their corresponding ventricles but the great arteries emerge from
the “wrong” ventricle) and congenitally corrected transpositions
with atrioventricular and ventriculoarterial discordance [the right
atrium (inﬂux of venous blood) is connected to the left ventricle
from which the pulmonary artery originates and the left atrium
(inﬂux of arterial blood) is coupled to the right ventricle from
which the aorta emerges]. In the ﬁrst condition, both circuits (sys-
temic and pulmonary circulation) run in parallel resulting in a
severe hypoxemic status in which the survival depends on the ade-
quate mixing between the two circulations be it via a VSD or ASD
or a patent ductus arteriosus Botalli, whereas in the second condi-
tion (systemic and pulmonary circulation run in series) patients
could remain asymptomatic over a longer period of time.
The exact etiology of this cardiac defect still remains unde-
tected. However, some risk factors like maternal diabetes mellitus
(Lisowski et al., 2010), herbicides (Loffredo et al., 2001), mater-
nal use of antiepileptic medication (Thomas et al., 2008) have
been identiﬁed as well as some cases associated with the DiGe-
orge syndrome (Laitenberger et al., 2008). Although neural crest
cell migration plays a signiﬁcant role in the pathogenesis of
conotruncal heart defects, surprisingly, TGA could not be detected
experimentally after neural crest ablation (Kirby, 2002). Interest-
ingly enough, Costell et al. (2002) presented a mouse model of
perlecan (heparan sulfate proteoglycan 2) null mutation exhibit-
ing the cardiac phenotype of complete TGA, and the authors
concluded from their study that perlecan has a role in the orga-
nization and differentiation of the outﬂow tract mesenchyme.
Additionally, the highly mutagenic agent N-ethyl-N-nitrosourea
FIGURE 4 |Transposition of the great arteries.The ventriculoarterial
discordance with the pulmonary artery connected to the left and the aorta
connected to the right ventricle is shown. Also depicted is an atrial and
ventricular septal defect and a patent ductus arteriosus Botalli. The blue
arrows give the ﬂow of oxygen-poor blood from both caval veins via the right
atrium and the right ventricle to the aorta. The red arrows give the ﬂow of
oxygen-rich blood from the pulmonary veins via the left atrium and the left
ventricle to the pulmonary artery.
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also had the ability to induce TGA in mice, but more com-
monly TAC and outﬂow tract anomalies together with coronary
aneurysms were seen (Yu et al., 2004). Whether this Cx43 point
mutation described in the study of Yu et al. (2004), which was
found together with outﬂow tract anomalies, might also account
for theheart defect“transpositionof the great arteries”still remains
to be elucidated. However, it was shown in a very recent study
on human myocardial anomalies including TGA that N-cadherin
and Cx43 expression and distribution was not altered in both left
and right ventricle as compared to normal hearts (Mahtab et al.,
2012). Although in this study the number of cases is consider-
ably small (only three hearts were examined) the authors could
clearly show that Cx43 together with N-cadherin accrued at the
intercalated diskswith a normal pattern. To date, there are no stud-
ies available describing pathological alterations of Cx40, Cx43, or
Cx45 having a causal relationship in the development of TGA.
However, in a study of Haeﬂiger et al. (2000) done in mice the
inﬂuence of another connexin, the Cx37, on this cardiac defect
was examined. This connexin isoform, expressed in larger quan-
tities in endothelial cells in a number of vessels and only very
sparsely in cardiomyocytes, seems to play a not unimportant role
in conotruncal development. Mice treated with all-trans retinoic
acid during early embryonic life exhibited complete transposition
of aorta and pulmonary arteries. Ventricles of these mice showed
an abnormal high expression of Cx37, but whether the expres-
sion level of Cx37 is really a co-factor for the heart defect TGA is
not ﬁnally clariﬁed, as it seems so that the Cx37 over-expression
was not directly linked to that cardiac malformation (Haeﬂiger
et al., 2000). Nevertheless, it should be taken into account that
Cx37 typically is expressed in vascular endothelium and thus
the described malformations may also be inﬂuenced by changes
in angiogenesis or vascular function. However, this is unclear
at present.
DOUBLE OUTLET RIGHT VENTRICLE
The characteristic of this heart defect is the origination of both
great arteries (aorta and pulmonary artery) from the right ven-
tricle (shown in Figure 5). This malformation occurs in variable
forms depending on the degree of malposition of the great arter-
ies, the location of the concomitant VSD and the occurrence of
RVOT obstruction. Thus, a distinction can be made between a
VSD-type double outlet right ventricle (DORV; VSD with sub-
aortic location), Fallot-type DORV (VSD with sub-aortic location
and pulmonary stenosis) and TGA-type DORV (VSD with sub-
pulmonary location, Taussig–Bing syndrome; Artrip et al., 2006).
Therefore, depending on the exact morphology of the DORV, the
clinical manifestation is different: DORV physiology might resem-
ble a large unrestrictive VSD, a TOF or a TGA. This heterogeneity
also implies different operative approaches and the timing of
surgical repair. Associated cardiac malformations include a juxta-
position of atrial appendages, obstruction of the aortic arch,mitral
atresia, or atrioventricular septal defects. Moreover, extracardiac
manifestations can be found, such as heterotaxia, esophageal atre-
sia, exomphalos, and chromosomal anomalies like the trisomy 18
(Tennstedt et al., 1999). An involvement of the neural crest zone
in the development of DORV has been described, but as outlined
in the comprehensive review of Obler et al. (2008) disturbances in
neural crest cell migration might not be the unique reason for the
formation of a DORV.
About 10 years ago, Gu et al. (2003) published a study about
Cx40 homozygous null mice, showing that if Cx40 is completely
knocked-out cardiac malformations like DORV or TOF occurred.
However, given the fact that only 30% of the Cx40−/− mice
exhibited cardiacmalformations the authors suggested that down-
regulation of Cx40 in the neural crest zone might play an indirect
role in the development of the described heart defects. Moreover,
a very recent study in mice revealed that if Hand2 (a transcription
factor involved in the morphogenesis of limbs), which is expressed
in cardiac neural crest cells and also in the right ventricle and out-
ﬂow tract, is deleted outﬂow tract anomalies, i.e., DORV and
VSD occurred (Holler et al., 2010). The authors also found that
Cx40, which is expressed in neural crest cells of wild-type mice,
was signiﬁcantly reduced in the Hand2 knock-out mice and they
concluded from their experiments that Hand2 directly binds to
the Cx40 promoter, thereby enhancing Cx40 expression, and that
intercellular communication is a critical part for a proper outﬂow
tract development.
A human study focusing on possible mutations of Cx43 in
the development of cardiac defects was done on cardiac mate-
rial of aborted fetuses, and the authors reported on eight Cx43
mutations which they found in a heart with DORV (Chen et al.,
2005). These mutations were in the C-terminus near the trans-
membrane region and one mutation (the Pro283Leu missense
mutation) was thought to limit Cx43 degradation. As the amount
of Cx43 is important for the development of the conotruncus the
authors concluded that this point mutation might be involved in
the occurrence of DORV.
TETRALOGY OF FALLOT
In the year 1888, the French physician Étienne-Louis Arthur Fallot
described a congenital heart defect with four cardiac malforma-
tions: (1) right ventricular hypertrophy, (2) pulmonary stenosis
(valvular or infundibular), (3) VSD with (4) overriding of the
aortic root (Figure 6). This congenital heart anomaly is the most
frequent inborn cyanotic heart disease. Nowadays, in infants with
Morbus Fallot primary repair is done in early childhood, mostly
below the age of 1 year, and the prognosis of these patients is
excellent with most of them reaching adulthood (Shinebourne
et al., 2006; Christian et al., 2009). Associated with Morbus Fallot
anomalies of the coronary arteries, ASDs, a right aortic arch and
also extracardial anomalies like gastrointestinal or facial anomalies
might exist (Piran et al., 2011). TOF typically occurs sporadically,
but also familiar recurrences have been described. The etiology
is multifactorial, but maternal diabetes mellitus, maternal intake
of retinoic acid, and phenylketonuria have been reported as risk
factors (Bailliard and Anderson, 2009). Moreover, an association
with chromosomal anomalies which include trisomy 13, 18, and
21 exist. Especially the coincidence of Morbus Fallot together
with 22q11.2 microdeletion is not infrequent. Maeda et al. (2000)
reported in a study that of 212 Japanese patients 28 patients (13%)
had 22q11.2 microdeletion and that all of these 28 patients had at
least one extracardiac abnormality. Thus, the authors concluded
that, at least in syndromic Morbus Fallot, 22q11.2 microdeletion is
quite common (Maeda et al., 2000), although its pathogenetic role
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FIGURE 5 | Double outlet right ventricle (VSD-type). Origination of
both great arteries (aorta and pulmonary artery) from the right ventricle
with a concomitant ventricular septal defect. The blue arrows give the
ﬂow of oxygen-poor blood from both caval veins via the right atrium
and the right ventricle to the pulmonary artery and aorta. The
red arrows give the ﬂow of oxygen-rich blood from the
pulmonary veins via the left atrium, the left ventricle to the
aorta.
is still unclear. Moreover, some studies involving non-syndromic
TOF described dominant mutations in genes encoding for vari-
ous transcription factors, like GATA4, Nkx2.5, or ZFMP2/FOG2
(Goldmuntz et al., 2001; Nemer et al., 2006; De Luca et al., 2011).
Given the accepted fact that regular Cx43 expression is impor-
tant for neural crest development (Waldo et al., 1999) the question
arises if mutations in the Cx43 gene might also be responsible for
the occurrence of Morbus Fallot. A very early publication on this
subject was done by Reaume et al. (1995), who created a Cx43
knock-out mouse and could demonstrate that these mice had out-
ﬂow tract anomalies and died soon after birth. However, the full
picture of Morbus Fallot was not seen, suggesting that additional
factors might be required. Few years later Sullivan et al. (1998)
presented a study in which they used a dominant negative strategy
to reduce gap junctional coupling within the cardiac neural crest
cells. They could also demonstrate that outﬂow tract obstruction,
right ventricular hypertrophy, and abnormal bulging of the right
ventricle occurred, but the full syndrome of Morbus Fallot was not
observed.
One recent study seemed to conﬁrm the ﬁndings of Britz-
Cunningham et al. (1995) on mutations in the C-terminus tail of
Cx43 in patients with inborn cardiac defects (Wang et al., 2010).
In the analysis of Wang et al. (2010) over 400 Chinese children
were included. Most of these children had VSDs or ASDs or
Morbus Fallot, and three heterozygous missense mutations in
the C-terminus were found in all these patients with congeni-
tal heart defects, whereas no mutations were detectable in the
normal control subjects. As the C-terminus includes important
phosphorylation sites (Figure 1) the authors concluded that the
mutations could have an impact on the structure of Cx43 and on
normal channel function. In contrast, 1 year later another very
interesting study came to a radically opposed conclusion: in this
study, 300 patients with conotruncal heart defects including Fal-
lot’s Tetralogy were investigated and the authors discovered two
silent mutations in the Cx43 gene in eight patients, but no muta-
tions were found which would alter Cx43 amino acid sequence
(Huang et al., 2011). Moreover, this working group constructed
a mouse model with homozygous or heterozygous mutations of
serine residues known to be targeted by PKC or CK1 (casein kinase
1), both enzymes being important for channel conductance and
the assembly of Cx43 gap junction channels. Surprisingly, in the
hearts of these mice, which were viable with a normal life-span,
no changes in Cx43 distribution or expression, and no congeni-
tal heart defects, were detected. The authors concluded that Cx43
does not contribute to a large extent to the development of heart
malformations. Thus, the question of whether or not mutation in
Cx43 gene is involved in the origination of Morbus Fallot remains
unsolved.
Another study group analyzed Cx43 expression and distribu-
tion in patients with Morbus Fallot and they found that in these
patients Cx43, which is normally conﬁned to the poles of the car-
diomyocytes, was distributed around the entire circumference of
the cells. Moreover, total Cx43 staining, analyzed by a ﬂuorescence
activated cell sorting (FACS)-approach, was signiﬁcantly lower in
the patient group having Morbus Fallot compared to the control
group (patients with VSDs; Kołcz et al., 2002, 2005). The authors
concluded from their studies that these connexin alterationsmight
be responsible for cardiac arrhythmias, seen frequently in patients
with Morbus Fallot and that changes in Cx43 localization might
contribute to a dysfunction of the right ventricle. However, it
should be noted that histological analyses were not carried out on
the intact heart tissue but on single cardiomyocytes cultured in
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FIGURE 6 |Tetralogy of Fallot. Depicted are the four cardiac malformations
described by Fallot: (1) right ventricular hypertrophy, (2) pulmonary stenosis
(valvular and infundibular), (3) ventricular septal defect with (4) overriding of
the aortic root. The blue arrows give the ﬂow of oxygen-poor blood from both
caval veins via the right atrium and the right ventricle to the pulmonary artery
and via the ventricular septal defect to the aorta (right–left shunt). The red
arrows give the ﬂow of oxygen-rich blood from the pulmonary veins via the
left atrium and the left ventricle to the aorta.
Petri dishes. Since Cx43 has a very short half-time it is not unlikely
that the described Cx43 re-distribution is more due to the culture
conditions than to the heart defect or a more complex response of
somehow altered cardiomyocytes to the culture conditions. In the
end, the precise role of Cx43 in the development of Morbus Fallot
cannot be assessed.
Given the information that the other important connexin,
Cx40, is also involved in cardiac morphogenesis, several working
groups have analyzed this connexin in relation to the occurrence
of TOF. These studies done in man revealed that Morbus Fallot
was associated with above-average frequency with copy number
variants in the Cx40 gene (Greenway et al., 2009; Soemedi et al.,
2012). Moreover, it was shown by Greenway et al. (2009) that in
TOF patients Cx40 expression in RVOT, which is malformed in
Fallot’s Tetralogy, was enhanced. This ﬁnding could indicate that
Cx40 might be among the disease genes involved in the occurrence
of Morbus Fallot.
Since mutations in the C-terminus of Cx43 have been found in
TOF patients, another interesting aspect to consider would be if
the C-terminal end of Cx40 might also be mutated in patients with
Morbus Fallot. A very interesting study published this year (Guida
et al., 2013) characterized over 150 patients with non-syndromic
Fallot and found in 1% of their patients a heterozygous nucleotide
change in the Cx40 gene leading to altered amino acid sequence.
This Pro265Ser variant was not seen in healthy volunteers [amino
acid 265 is the binding region for src (sarcoma Rous kinase)].
Further experiments of this working group on the cellular level
revealed that this mutant Cx40 led to a reduced gap junctional
coupling. In addition, introducing the Pro265Ser mutant of Cx40
into zebraﬁshes also was associated with malformations of the
heart tube.
However, a deﬁnite clariﬁcation whether connexins are causally
involved in the development of Morbus Fallot or whether their
change in expression is an epiphenomenon is still pending.
POSSIBLE MOLECULAR MECHANISMS
The role of connexins in the development of cardiacmalformation
has emerged over the past decade by introducing the knock-in and
knock-out mice and a lot of research has been done in this ﬁeld.
However, still only little is known about the signaling pathways in
these mice to unravel how connexin alterations might be linked
to the origination of conotruncal heart defects. By contrast, some
studies have been published which used an approach from a dif-
ferent perspective. Dupays et al. (2005) described in their study
results on Nkx2.5-deﬁcient mice. They found out that in homozy-
gous Nkx2.5 null mice embryos Cx40, Cx43, and Cx45 could not
be detected within the myocardium,whereas these connexins were
still detectable in other organs. Moreover, although 75% of these
embryos had a normal sequence of cardiac activation and conduc-
tion along the conduction system, heart rate was very slow. In the
other remaining 25% of mutant mice the ventricle was the ﬁrst
chamber being activated thus showing a reverse action of cardiac
excitation. The Nkx2.5 null mice embryos also exhibited an insuf-
ﬁcient development of the ventricular trabeculae. Besides, heart
malformations like ASDs andVSDs have been seen although com-
plex cardiac malformations could not be detected maybe because
of premature death occurring in theses mice (Terada et al., 2011).
However, in man Nkx2.5 mutations are also associated with car-
diac malformations like ASDs and VSDs and additionally with
other more complex cardiac malformations (Morbus Fallot, pul-
monary atresia; Schott et al., 1998; Wang et al., 2011). However,
for obvious reasons analysis of connexin expression could not be
done in the patients hearts.
Another transcription factor which has been described in
the context of the Holt–Oram syndrome is the T-box tran-
scription factor Tbx5 (Basson et al., 1997). Patients suffer-
ing from this inborn syndrome have malformed limbs and
cardiac defects like ASD, VSD, and also more severe car-
diac malformations. In a mouse model of heterozygous
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Tbx5 mutants Bruneau et al. (2001) could demonstrate that a phe-
notype similar to the Holt–Oram syndrome occurred, and that
interestinglyCx40 gene expressionwas down-regulated in the atria
and ventricles of these mice.
GATA4 is another transcription factor known to be associated
with cardiac development. Recently, a point mutation of GATA4
was detected within a large cohort of kindred persons, who exhib-
ited ASDs and in some cases also VSDs and abnormalities of the
pulmonary valve (Garg et al., 2003). All these family members car-
ried a glycine to serine substitution at position 296 of GATA4,
which was accompanied by a diminished binding ability to the
DNA consensus sequence and in addition by reduced interaction
with Tbx5.
Consistent with all these ﬁndings Linhares et al. (2004) showed
that in the Cx40 promoter binding sites exist for Tbx5, Nkx2.5,
and GATA4. Both nuclear factors Nkx2.5 and GATA4 transactivate
the Cx40 promoter thereby regulating Cx40 expression. This was
compatible with the ﬁnding that in Nkx2-5 knock-out mice Cx40
expression was markedly down-regulated. On the other hand, the
nuclear factor Tbx5 seemed to have a more repressive role on the
Cx40 promoter, which was in contrast to the ﬁnding of Bruneau
et al. (2001), who demonstrated the opposite. A possible explana-
tion discussed by Linhares et al. (2004) would be that the promoter
sequence used in their study was considerably shorter than that
of Bruneau et al. (2001) therefore lacking important necessary
elements.
Thus, besides connexin mutations seen in human cardiac mal-
formations also mutations in transcription factors accompanied
by altered connexin expression might have an impact on inborn
heart defects.
However, a detailed description of how signaling pathways may
be linked to cardiac malformations awaits further studies.
Nevertheless, a problem with these mice knock-out studies is
that the ﬁnally resulting cardiac phenotype is not investigated with
regard to the molecular mechanisms linking the knock-out-target
to the cardiac development. Moreover, from a cardiological point
of view it is remarkable that mutations or knock-out in very differ-
ent genes very often result in ASDs or VSDs. This might indicate
that between connexins, transcription factors like Nkx2.5, Tbx5,
GATA4, etc. and cardiac malformations there might exist one (or
more) missing links which still need to be elucidated.
CONCLUSION
Taken together, until now there is no conclusive evidence that
human inborn conotruncal heart defects are caused by mutations
or changes in connexins. From the view point of cell biology it is
tempting to speculate that a protein so deeply involved in intercel-
lular communication, regulation of growth and differentiation as
well as of cell cycle could be involved in the pathogenesis of mal-
formation. However, although Cx43 knock-out mice can present
malformation of the RVOT with some similarity to Morbus Fallot,
this does not warrant the conclusion that Morbus Fallot results
from Cx43 changes. There probably are many regulatory steps
and proteins involved in cardiac organogenesis, so that the mal-
function of each and any may cause a common phenotype. This
leads to our present view that the pathogenesis of conotruncal
human inborn heart defects seems multifactorial and that there
is at present for the majority of inborn cardiac malformations no
evidence for a direct or causal role of connexins. Although, stud-
ies in mice revealed that at least in some cases of cardiac defects
a pathogenetic involvement of connexins might be evident, this
does not exclude that other proteins with an impact on protein
trafﬁcking or membrane anchoring may be involved and may lead
to secondary changes in connexins either as an epiphenomenon or
playing an aggravating role. In addition, the cardiac defect could
cause hemodynamic changes which would lead to altered local
stretch. Since stretch has an effect on cytoskeleton and on the
subcellular distribution of Cx43 (Salameh et al., 2010), this also
may lead to secondary changes in connexin expression and local-
ization. Whether such changes have a feedback effect on cellular
growth and differentiation is unclear. In summary, a direct unifac-
torial role of connexins in human inborn conotruncal heart defect
seems improbable, but a more complex role or a bystander effect
is reasonable.
Not chicken, not egg, but complex bidirectional interactions
between connexins and tissue developments and vice-versa.
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